Landong, Brinlie Jazz A.
HRN: 26-87-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/30/2025
04/06/2025
IV
65mg
Q 24
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes